American College of Clinical Pharmacy
      Search      Cart
         

2026 ACCP/ASHP Pain Management Pharmacy Preparatory Review and Recertification Course


Format to Purchase:
Member Price:
$---.--
Nonmember Price:
$---.--

The ACCP/ASHP Pain Management Pharmacy Preparatory Review and Recertification Course is ideal for pharmacy professionals who are preparing for the Pain Management Pharmacy Specialty Certification Examination administered by the Board of Pharmacy Specialties (BPS) and for those seeking a self-paced review and refresher of disease states and therapeutics.  

Developed by Board Certified Pharmacists and clinical experts, the course content is based on the domains, tasks and knowledge statements outlined in the BPS Pain Management Pharmacy content outline. The course content provides a comprehensive review of the knowledge domains covered in the specialty certification examination. The course uses case-based presentations for application to real-life scenarios, a practice exam along with correct answers, and links to the reference sources, and domains, tasks, and knowledge statements.  

Release Date: August 26, 2026
BCPMP Deadline: August 24, 2027
ACPE Deadline: August 26, 2029

Technical Requirements:

Contents

Principles of Pain and Pain Experience; Practice Management; Pain Stewardship; Research, Quality Improvement, and Ethics

Principles of Pain and Pain Experience

Practice Management

Pain Stewardship

Research, Quality Improvement, and Ethics

Opioids I; Opioids II; Non-opioid Pharmacologic Options; Nonpharmacologic, Complementary, and Integrative Therapies

Opioids I

Opioids II

Non-opioid Pharmacologic Options

Nonpharmacologic, Complementary, and Integrative Therapies 

Pain Management Challenges in Ambulatory Care; Acute and Critical Pain Management; Patient Identification: Risk Mitigation and Monitoring; Pharmacologic Delivery and Interventional Nuances

Pain Management Challenges in Ambulatory Care

Acute and Critical Pain Management

Patient Identification: Risk Mitigation and Monitoring

Pharmacologic Delivery and Interventional Nuances

Chronic Pain I; Chronic Pain II; Cancer-Related Pain; Palliative Care and Hospice

Chronic Pain I

Chronic Pain II

Cancer-Related Pain

Palliative Care and Hospice

Novel Non-opioid Pharmacotherapies; Headaches; Special Populations; Opioid Use Disorders and Behavioral Health

Novel Non-opioid Pharmacotherapies

Headaches

Special Populations

Opioid Use Disorders and Behavioral Health 

2026 ACCP/ASHP Pain Management Pharmacy Preparatory Review and Recertification Course

Various: See Modules

Principles of Pain and Pain Experience; Practice Management; Pain Stewardship; Research, Quality Improvement, and Ethics

*Content Matter Expert

Faculty

Mena Raouf, Pharm.D., BCPMP
Clinical Pharmacy Practitioner – Pain Management
Orlando VA Healthcare System
Orlando, Florida
Suzanne Amato Nesbit, Pharm.D., BCPMP, FCCP, FASHP
Clinical Pharmacy Specialist, Pain Management and Opioid Stewardship
The Johns Hopkins Hospital;
Interim Director, Graduate Clinical Education
Johns Hopkins University School of Medicine
Baltimore, Maryland
William J. Peppard, Pharm.D., FCCM, BCPS*
Pain Stewardship Coordinator
Froedtert ThedaCare Health;
Associate Professor of Surgery
Medical College of Wisconsin
Milwaukee, Wisconsin
Jacob T. Painter, Pharm.D., Ph.D., MBA
Professor
Department of Pharmacy Practice
University of Arkansas for Medical Sciences
Little Rock, Arkansas

Opioids I; Opioids II; Non-opioid Pharmacologic Options; Nonpharmacologic, Complementary, and Integrative Therapies

Faculty

Abigail T. Brooks, Pharm.D., BCPS
Clinical Pharmacist Practitioner, Pain Management
West Palm Beach Veterans Affairs Healthcare System;
Courtesy Clinical Assistant Professor
University of Florida College of Pharmacy
West Palm Beach, Florida
Emily M. McGovern, Pharm.D.*
Pain Management Clinical Pharmacist Practitioner
Samuel S. Stratton VA Medical Center
Albany, New York
Claire T. Brandt, Pharm.D., BCPMP, BCPS
Clinical Pharmacist Practitioner – Pain Management
VA Tennessee Valley Healthcare System
Murfreesboro, Tennessee
Anne Cetto, Pharm.D., BCPS
Clinical Pharmacy Practitioner – Pain Management
Central Arkansas Veterans Healthcare System
Little Rock, Arkansas

Pain Management Challenges in Ambulatory Care; Acute and Critical Pain Management; Patient Identification: Risk Mitigation and Monitoring; Pharmacologic Delivery and Interventional Nuances

Faculty

Leah R. Gregory, Pharm.D., BCGP, BCACP
Clinical Pharmacist
CoxHealth
Springfield, Missouri
Sara Jordan Hyland, Pharm.D., FCCP, BCCCP
Clinical Pharmacist, Perioperative and Emergency Medicine
OhioHealth Grant Medical Center, Department of Pharmacy
Columbus, Ohio
Lisa Luciani, Pharm.D., BCPS*
Clinical Pharmacist Practitioner – Pain Management
James E. Van Zandt VA Medical Center;
Pain Management, Opioid Safety, and PDMP (PMOP) Coordinator
Altoona, Pennsylvania
Nicole L. Eye, Pharm.D.
Pain Clinical Pharmacist
Avera McKennan Hospital and University Health Center
Sioux Falls, South Dakota

Chronic Pain I; Chronic Pain II; Cancer-Related Pain; Palliative Care and Hospice

Faculty

Erica L. Wegrzyn, Pharm.D.
Clinical Pharmacist Practitioner, Pain Management
Stratton VA Medical Center;
Adjunct Faculty
Albany College of Pharmacy and Health Sciences
Albany, New York
Jeffrey Bettinger, Pharm.D.
Pain Management Clinical Pharmacist
Saratoga Hospital Medical Group
Saratoga Springs, New York
Lisa M. Holle, Pharm.D., FCCP, FCPA, FHOPA, FISOPP, BCOP
Associate Professor (CHS)
University of Wisconsin-Madison School of Pharmacy
Madison, Wisconsin
Megan T. Mitchell, Pharm.D., MS, BCPMP
Pharmacy Clinical Coordinator, Pain Management and Palliative Care
UConn Health John Dempsey Hospital
Farmington, Connecticut

Novel Non-opioid Pharmacotherapies; Headaches; Special Populations; Opioid Use Disorders and Behavioral Health

Faculty

Neil K. Shah, Pharm.D., BCPS
Pain Management and Substance Use Disorders Clinical Pharmacy Specialist
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Jordan L. Wulz, Pharm.D., MPH, BCPMP, BC-ADM
Associate Professor of Pharmacy Practice
Concordia University Wisconsin, School of Pharmacy
Clinical Pharmacist
Progressive Community Health Center
Mequon, Wisconsin
Thomas B. Gregory, Pharm.D., BCPS, BCEMP*
Clinical Pharmacy Specialist
CoxHealth
Springfield, Missouri
Shelley S. Fortner, Pharm.D., BCPMP, BCPS
Pain Clinical Pharmacy Practitioner
North Florida/South Georgia Veterans Health System
Lake City, Florida

2026 ACCP/ASHP Pain Management Pharmacy Preparatory Review and Recertification Course

Faculty

Kevin W. Chamberlin, Pharm.D., FASCP, FCPA*
Chief Pharmacy Officer
UConn Health
Clinical Adjunct Associate Professor
UConn Schools of Medicine & Pharmacy
Farmington, Connecticut

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCPMP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.

Target Audience: The Pain Management Pharmacy Preparatory Review and Recertification Course is designed to help pharmacists who are preparing for the Board of Pharmacy Specialties certification examination in Pain Management Pharmacy as well as those seeking a general review and refresher on disease states and therapeutics.

Contents

Principles of Pain and Pain Experience; Practice Management; Pain Stewardship; Research, Quality Improvement, and Ethics

Activity Number: 0217-9999-26-192-H08-P
Contact Hour(s): 4.25
Activity Type: Application Based
Learning Objectives

Principles of Pain and Pain Experience

  1. Apply knowledge of pain physiology and pathophysiology to differentiate pain mechanisms and guide treatment selection.
  2. Differentiate between acute, chronic, neuropathic, nociceptive, nociplastic, and mixed pain.
  3. Interpret clinical presentations of pain to determine etiology and classification.
  4. Integrate patient-reported pain experiences with objective assessment methods to develop a patient-centered approach to pain management.

Practice Management

  1. Demonstrate effective communication strategies for educating patients, health care providers, and stakeholders about pain management.
  2. Apply general pain management guidelines to support clinical decision-making.
  3. Evaluate the impact of insurance coverage and formulary management on pain management treatment selection.
  4. Use collaborative practice agreements, independent prescribing principles, and clinical informatics tools to optimize pain management workflows.

Pain Stewardship

  1. Apply pain management stewardship principles to optimize therapeutic outcomes.
  2. Implement opioid stewardship strategies to enhance patient safety.
  3. Evaluate resource use in pain management to optimize clinical outcomes and safety.
  4. Examine the impact of pain management policies on patient safety, health equity, and clinical effectiveness.
  5. Demonstrate an understanding of practice guidelines, regulatory standards, and benchmarks in pain management practices.

Research, Quality Improvement, and Ethics

  1. Apply principles of epidemiologic study design, randomization, blinding, and statistical inference to critically assess pain management research.
  2. Calculate key biostatistical measures to evaluate the significance of pain management research findings.
  3. Interpret FDA analgesic drug guidance to judge whether trial designs, end points, and treatment effects meet current regulatory expectations.
  4. Analyze the ethical implications of placebo and nocebo effects as related to research critique and everyday clinical communication.

Opioids I; Opioids II; Non-opioid Pharmacologic Options; Nonpharmacologic, Complementary, and Integrative Therapies

Activity Number: 0217-9999-26-193-H08-P
Contact Hour(s): 4.75
Activity Type: Application Based
Learning Objectives

Opioids I

  1. Apply pharmacologic principles of opioid analgesics to assess dosing, efficacy, and safety considerations in pain management.
  2. Evaluate the impact of pharmacogenetic variations on opioid metabolism and patient response.
  3. Calculate opioid doses and conversions to ensure safe and effective pain management.
  4. Identify potential drug interactions, contraindications, and safety concerns associated with opioid use.
  5. Select an appropriate opioid for a given patient.

Opioids II

  1. Compare the mechanisms of action, pharmacokinetics, and pharmacodynamics of nontraditional opioid analgesics.
  2. Assess the role of pharmacogenetics in patient response to methadone, buprenorphine, tramadol, and other nontraditional opioids.
  3. Determine appropriate opioid dose transition strategies for methadone, buprenorphine, and other nontraditional agents.
  4. Evaluate safety concerns, contraindications, and drug interactions unique to nontraditional opioids.
  5. Integrate knowledge into patient-specific cases.

Non-opioid Pharmacologic Options

  1. Evaluate the appropriateness of non-opioid analgesics on the basis of patient-specific factors.
  2. Recommend appropriate dosing of non-opioid medications using pharmacokinetic (PK), pharmacodynamic (PD), and pharmacogenetic (PG) principles.
  3. Assess the efficacy and safety of non-opioid analgesics on the basis of available clinical evidence and drug properties.
  4. Select appropriate non-opioid analgesics for pain management on the basis of pain type, therapeutic goals, and indications.
  5. Apply evidence-based guidelines to optimize non-opioid analgesic use.

Nonpharmacologic, Complementary, and Integrative Therapies

  1. Distinguish between mind-body, active physical, and passive physical interventions on the basis of their mechanisms, benefits, and risks in pain management.
  2. Analyze the impact of cognitive and behavioral therapies, including cognitive behavioral therapy (CBT) and mindfulness, on chronic pain management.
  3. Examine the effectiveness of active physical interventions, such as physical therapy and structured exercise, in treating pain conditions.
  4. Determine the appropriate use of passive physical interventions, including acupuncture, chiropractic care, and transcutaneous electrical nerve stimulation (TENS), on the basis of clinical evidence.
  5. Integrate findings from key clinical studies to support the use of nonpharmacologic therapies in comprehensive pain management plans.

Pain Management Challenges in Ambulatory Care; Acute and Critical Pain Management; Patient Identification: Risk Mitigation and Monitoring; Pharmacologic Delivery and Interventional Nuances

Activity Number: 0217-9999-26-194-H08-P
Contact Hour(s): 6.00
Activity Type: Application Based
Learning Objectives

Pain Management Challenges in Ambulatory Care

  1. Apply evidence-based pain scales and risk factor identification to assess acute pain in ambulatory patients.
  2. Implement appropriate methadone, naltrexone, or buprenorphine management in the perioperative pain plan for ambulatory surgery patients with opioid use disorder.
  3. Select appropriate analgesic strategies for acute dental pain in the ambulatory setting.
  4. Recommend appropriate analgesic strategies, including dosing and breakthrough pain management, for ambulatory patients with renal colic.
  5. Determine appropriate monitoring values and criteria for escalation of care in the follow-up of ambulatory patients with acute pain.

Acute and Critical Pain Management

  1. Recommend pharmacotherapeutic strategies for acute pain in trauma patients.
  2. Implement evidence-based pain management strategies for ICU patients with complex conditions (eg, burns, pancreatitis) to achieve optimal pain control.
  3. Assess pain in critically ill patients using validated assessment tools and by interpreting physiological indicators and behavioral cues.

Patient Identification: Risk Mitigation and Monitoring

  1. Differentiate key terminology related to opioid use and misuse to accurately assess and communicate patient risks.
  2. Use validated risk assessment tools and clinical strategies to identify and treat patients at high risk of opioid misuse or overdose.
  3. Incorporate prescription drug monitoring program (PDMP) data, informed consent, and harm reduction strategies (eg, naloxone co-prescribing, safe storage) into opioid risk mitigation plans.
  4. Implement risk-reduction measures such as naloxone prescribing, safe storage education, and suicide prevention strategies in clinical practice.
  5. Analyze urine drug screening (UDS) results to differentiate between screening and confirmatory tests, recognize potential false-positives, and assess adherence. 

Pharmacologic Delivery and Interventional Nuances

  1. Evaluate parenteral pain management techniques (eg, intravenous, intramuscular) for appropriateness and effectiveness in patients.
  2. Apply principles of patient-controlled analgesia (PCA) to assess and adjust pain management strategies.
  3. Implement regional and neuraxial analgesia techniques in diverse clinical scenarios.
  4. Recommend appropriate routes of administration and delivery devices (eg, intrathecal pumps, intranasal sprays, elastomeric pumps) on the basis of individual patient factors to optimize pain management.

Chronic Pain I; Chronic Pain II; Cancer-Related Pain; Palliative Care and Hospice

Activity Number: 0217-9999-26-195-H08-P
Contact Hour(s): 5.00
Activity Type: Application Based
Learning Objectives

Chronic Pain I   

  1. Differentiate peripheral neuropathy, phantom limb pain, post-stroke pain, chronic lower back pain, and chronic spine disorders on the basis of their etiology, pathophysiology, and clinical presentation.
  2. Use appropriate pain assessment tools and diagnostic strategies to evaluate and distinguish between these chronic pain conditions.
  3. Apply clinical guidelines and relevant trials to support evidence-based diagnostic and monitoring approaches for each condition.
  4. Develop patient-centered pain management plans that align with assessment findings and patient goals for these chronic pain conditions.

Chronic Pain II

  1. Distinguish complex regional pain syndrome, musculoskeletal pain, osteoarthritis, visceral pain, and fibromyalgia by examining their underlying causes, disease mechanisms, and symptomatology.
  2. Implement appropriate pain assessment tools and diagnostic modalities to accurately identify and evaluate these chronic pain syndromes.
  3. Integrate evidence from clinical practice guidelines and key studies to inform diagnostic and monitoring decisions for each condition.
  4. Formulate individualized pain management strategies that incorporate patient-specific assessment data and therapeutic goals.

Cancer-Related Pain

  1. Apply evidence-based strategies for assessing and managing pain in patients with cancer.
  2. Assess opioid and adjuvant analgesic therapies in patients with cancer-related pain.
  3. Integrate palliative care principles into pain management for patients with advanced cancer.
  4. Evaluate challenges in oncologic pain management, including neuropathic pain and bone pain. 

Palliative Care and Hospice

  1. Differentiate palliative care, hospice care, and survivorship to guide appropriate patient referrals and interventions.
  2. Assess pain and symptom management strategies for patients receiving palliative or hospice care.
  3. Apply communication techniques to discuss goals of care, advance directives, and end-of-life decision-making with patients and caregivers.
  4. Develop an individualized care plan that addresses physical, emotional, and psychosocial needs in palliative and end-of-life settings.

Novel Non-opioid Pharmacotherapies; Headaches; Special Populations; Opioid Use Disorders and Behavioral Health

Activity Number: 0217-9999-26-196-H08-P
Contact Hour(s): 5.25
Activity Type: Application Based
Learning Objectives

Novel Non-opioid Pharmacotherapies  

  1. Integrate the mechanisms of action, pharmacokinetics, and pharmacodynamics of novel non-opioid analgesics into clinical decision-making for patient-specific pain management strategies. 
  2. Assess the safety profiles, side effects, and contraindications of suzetrigine, ketamine, lidocaine, cannabinoids, botulinum toxin, low-dose naltrexone, and magnesium.
  3. Evaluate the clinical safety of novel non-opioid analgesics according to kidney and hepatic function considerations.
  4. Apply evidence from major clinical studies to support the appropriate use of novel non-opioid analgesics in pain management.

Headaches

  1. Differentiate migraine (with and without aura), tension, cluster, and rebound headaches based on pathophysiology, clinical presentation, and diagnostic criteria.
  2. Select appropriate assessment tools and diagnostic strategies to evaluate headache disorders and rule out secondary causes.
  3. Apply clinical guidelines and evidence-based practices to develop individualized acute treatment plans for various headache types.
  4. Develop prophylactic treatment strategies based on patient-specific factors, headache frequency, and comorbid conditions.
  5. Implement headache management by incorporating patient-reported outcomes, lifestyle modifications, and pharmacologic/non-pharmacologic interventions.

Special Populations

  1. Assess pain management strategies in patients with sickle cell disease.
  2. Select appropriate pain management approaches for older adult patients, accounting for age-related physiological changes and medication safety concerns.
  3. Implement pain management strategies for pregnant patients.
  4. Propose pediatric-specific pain assessment and treatment strategies.
  5. Apply strategies to reduce disparities in pain management.

Opioid Use Disorders and Behavioral Health

  1. Integrate pharmacologic and nonpharmacologic strategies for managing both pain and mood/psychiatric disorders, as well as opioid use disorder (OUD).
  2. Formulate comprehensive treatment plans for patients with comorbid pain and behavioral health conditions like anxiety, depression, insomnia and OUD.
  3. Implement pharmacotherapy for patients with pain with co-occurring and mood/psychiatric disorders, as well as OUD.
  4. Assess the appropriateness and effectiveness of pain management in patients with co-occurring behavioral health conditions.
  5. Evaluate challenges of polypharmacy for patients with chronic pain and behavioral health conditions.

2026 ACCP/ASHP Pain Management Pharmacy Preparatory Review and Recertification Course

Activity Number:
Contact Hour(s): 25.25
Activity Type: Application Based
Learning ObjectivesVarious: See Modules

Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.